Optionsscheine finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
1000+ Ergebnisse
| MN63R9 |  | BioNTech SE (ADRs)/OS/Call [102,5]/MS | - | - | 102,500 | call | BioNTech SE (ADRs) | 112,500 | 79,139 % | - | - | - | 16.10.2026 | 1,000 | Morgan Stanley | |
| MN63R8 | | BioNTech SE (ADRs)/OS/Call [102,5]/MS | - | - | 102,500 | call | BioNTech SE (ADRs) | 112,500 | - | - | - | - | 19.03.2027 | 1,000 | Morgan Stanley | |
| PJ8XYM | | BioNTech SE (ADRs)/OS/Call [102]/BNP | - | - | 102,000 | call | BioNTech SE (ADRs) | - | 49,982 % | 0,350 | -0,039 | 8,288 | 18.09.2026 | 0,100 | BNP Paribas | |
| PK4X43 | | BioNTech SE (ADRs)/OS/Call [102]/BNP | - | - | 102,000 | call | BioNTech SE (ADRs) | - | 50,876 % | 0,468 | -0,028 | 4,799 | 18.12.2026 | 0,100 | BNP Paribas | |
| PK55DZ | | BioNTech SE (ADRs)/OS/Call [102]/BNP | - | - | 102,000 | call | BioNTech SE (ADRs) | - | 49,991 % | 0,476 | -0,025 | 4,512 | 15.01.2027 | 0,100 | BNP Paribas | |
| PM46L0 | | BioNTech SE (ADRs)/OS/Call [102]/BNP | - | - | 102,000 | call | BioNTech SE (ADRs) | - | 51,113 % | 0,510 | -0,022 | 3,800 | 19.03.2027 | 0,100 | BNP Paribas | |
| GU8GUL | BioNTech SE (ADRs)/OS/Call [102]/GOLDS | - | - | 102,000 | call | BioNTech SE (ADRs) | - | 57,719 % | 0,590 | -0,019 | 2,625 | 17.09.2027 | 0,100 | Goldman Sachs | ||
| GU8GV6 | BioNTech SE (ADRs)/OS/Call [102]/GOLDS | - | - | 102,000 | call | BioNTech SE (ADRs) | - | 57,514 % | 0,567 | -0,021 | 2,926 | 17.06.2027 | 0,100 | Goldman Sachs | ||
| GU8GWH | BioNTech SE (ADRs)/OS/Call [102]/GOLDS | - | - | 102,000 | call | BioNTech SE (ADRs) | - | 54,727 % | 0,520 | -0,024 | 3,572 | 19.03.2027 | 0,100 | Goldman Sachs | ||
| GU8KG3 | BioNTech SE (ADRs)/OS/Call [102]/GOLDS | - | - | 102,000 | call | BioNTech SE (ADRs) | - | 56,743 % | 0,612 | -0,016 | 2,390 | 21.01.2028 | 0,100 | Goldman Sachs | ||
| GW1SDZ | BioNTech SE (ADRs)/OS/Call [102]/GOLDS | - | - | 102,000 | call | BioNTech SE (ADRs) | - | 57,437 % | 0,607 | -0,017 | 2,433 | 17.12.2027 | 0,100 | Goldman Sachs | ||
| MK56RJ | | BioNTech SE (ADRs)/OS/Call [102]/MS | - | - | 102,000 | call | BioNTech SE (ADRs) | - | 60,868 % | 0,490 | -0,032 | 4,072 | 18.12.2026 | 0,100 | Morgan Stanley | |
| MM8J8L | | BioNTech SE (ADRs)/OS/Call [102]/MS | - | - | 102,000 | call | BioNTech SE (ADRs) | - | 62,108 % | 0,575 | -0,022 | 2,756 | 17.06.2027 | 0,100 | Morgan Stanley | |
| MM8JV0 | | BioNTech SE (ADRs)/OS/Call [102]/MS | - | - | 102,000 | call | BioNTech SE (ADRs) | - | 63,924 % | 0,401 | -0,052 | 6,326 | 18.09.2026 | 0,100 | Morgan Stanley | |
| MN0F27 | | BioNTech SE (ADRs)/OS/Call [102]/MS | - | - | 102,000 | call | BioNTech SE (ADRs) | - | 73,222 % | 0,648 | -0,020 | 2,023 | 17.12.2027 | 0,100 | Morgan Stanley | |
| MN680X | | BioNTech SE (ADRs)/OS/Call [102]/MS | - | - | 102,000 | call | BioNTech SE (ADRs) | - | 60,630 % | 0,543 | -0,026 | 3,232 | 19.03.2027 | 0,100 | Morgan Stanley | |
| MR34WH | | BioNTech SE (ADRs)/OS/Call [102]/MS | - | - | 102,000 | call | BioNTech SE (ADRs) | - | 88,260 % | 0,721 | -0,018 | 1,603 | 16.06.2028 | 0,100 | Morgan Stanley | |
| UJ3R5D | BioNTech SE (ADRs)/OS/Call [102]/UBS | - | - | 102,000 | call | BioNTech SE (ADRs) | - | - | - | - | - | 18.12.2026 | 0,100 | UBS | ||
| UJ6ZU6 | BioNTech SE (ADRs)/OS/Call [102]/UBS | - | - | 102,000 | call | BioNTech SE (ADRs) | - | - | - | - | - | 18.09.2026 | 0,100 | UBS | ||
| UJ543X | BioNTech SE (ADRs)/OS/Call [102]/UBS | - | - | 102,000 | call | BioNTech SE (ADRs) | - | - | - | - | - | 17.06.2027 | 0,100 | UBS | ||
| UQ9F8C | BioNTech SE (ADRs)/OS/Call [102]/UBS | - | - | 102,000 | call | BioNTech SE (ADRs) | - | - | - | - | - | 19.03.2027 | 0,100 | UBS | ||
| WA3CYY | BioNTech SE (ADRs)/OS/Call [102]/UBS | - | - | 102,000 | call | BioNTech SE (ADRs) | - | - | - | - | - | 15.01.2027 | 0,100 | UBS | ||
| UR0BXL | | BioNTech SE (ADRs)/OS/Call [102]/UniCredit | - | - | 102,000 | call | BioNTech SE (ADRs) | 112,000 | - | - | - | - | 15.12.2027 | 1,000 | Unicredit | |
| GU8GUJ | BioNTech SE (ADRs)/OS/Call [103]/GOLDS | - | - | 103,000 | call | BioNTech SE (ADRs) | - | 57,980 % | 0,584 | -0,019 | 2,630 | 17.09.2027 | 0,100 | Goldman Sachs | ||
| GU8GVK | BioNTech SE (ADRs)/OS/Call [103]/GOLDS | - | - | 103,000 | call | BioNTech SE (ADRs) | - | 58,002 % | 0,560 | -0,021 | 2,926 | 17.06.2027 | 0,100 | Goldman Sachs | ||
| GU8GVZ | BioNTech SE (ADRs)/OS/Call [103]/GOLDS | - | - | 103,000 | call | BioNTech SE (ADRs) | - | 53,540 % | 0,508 | -0,023 | 3,675 | 19.03.2027 | 0,100 | Goldman Sachs | ||
| GU8KDX | BioNTech SE (ADRs)/OS/Call [103]/GOLDS | - | - | 103,000 | call | BioNTech SE (ADRs) | - | 57,624 % | 0,613 | -0,016 | 2,364 | 21.01.2028 | 0,100 | Goldman Sachs | ||
| MK56RK | | BioNTech SE (ADRs)/OS/Call [103]/MS | - | - | 103,000 | call | BioNTech SE (ADRs) | - | 60,804 % | 0,480 | -0,032 | 4,115 | 18.12.2026 | 0,100 | Morgan Stanley | |
| MM8J8M | | BioNTech SE (ADRs)/OS/Call [103]/MS | - | - | 103,000 | call | BioNTech SE (ADRs) | - | 62,063 % | 0,568 | -0,023 | 2,774 | 17.06.2027 | 0,100 | Morgan Stanley | |
| MM8JV1 | | BioNTech SE (ADRs)/OS/Call [103]/MS | - | - | 103,000 | call | BioNTech SE (ADRs) | - | 64,709 % | 0,394 | -0,052 | 6,252 | 18.09.2026 | 0,100 | Morgan Stanley | |
| MN0F28 | | BioNTech SE (ADRs)/OS/Call [103]/MS | - | - | 103,000 | call | BioNTech SE (ADRs) | - | 73,104 % | 0,644 | -0,020 | 2,033 | 17.12.2027 | 0,100 | Morgan Stanley | |
| MN680Y | | BioNTech SE (ADRs)/OS/Call [103]/MS | - | - | 103,000 | call | BioNTech SE (ADRs) | - | 60,521 % | 0,530 | -0,026 | 3,281 | 19.03.2027 | 0,100 | Morgan Stanley | |
| MR34WJ | | BioNTech SE (ADRs)/OS/Call [103]/MS | - | - | 103,000 | call | BioNTech SE (ADRs) | - | 88,388 % | 0,721 | -0,019 | 1,602 | 16.06.2028 | 0,100 | Morgan Stanley | |
| GU8GUA | BioNTech SE (ADRs)/OS/Call [104]/GOLDS | - | - | 104,000 | call | BioNTech SE (ADRs) | - | 56,497 % | 0,544 | -0,021 | 3,031 | 17.06.2027 | 0,100 | Goldman Sachs | ||
| GU8GUK | BioNTech SE (ADRs)/OS/Call [104]/GOLDS | - | - | 104,000 | call | BioNTech SE (ADRs) | - | 58,148 % | 0,578 | -0,019 | 2,641 | 17.09.2027 | 0,100 | Goldman Sachs | ||
| GU8GVS | BioNTech SE (ADRs)/OS/Call [104]/GOLDS | - | - | 104,000 | call | BioNTech SE (ADRs) | - | 53,486 % | 0,498 | -0,023 | 3,709 | 19.03.2027 | 0,100 | Goldman Sachs | ||
| GU8KGC | BioNTech SE (ADRs)/OS/Call [104]/GOLDS | - | - | 104,000 | call | BioNTech SE (ADRs) | - | 56,780 % | 0,601 | -0,016 | 2,413 | 21.01.2028 | 0,100 | Goldman Sachs | ||
| GW1SDY | BioNTech SE (ADRs)/OS/Call [104]/GOLDS | - | - | 104,000 | call | BioNTech SE (ADRs) | - | 57,313 % | 0,595 | -0,017 | 2,463 | 17.12.2027 | 0,100 | Goldman Sachs | ||
| MK56RL | | BioNTech SE (ADRs)/OS/Call [104]/MS | - | - | 104,000 | call | BioNTech SE (ADRs) | - | 61,889 % | 0,477 | -0,033 | 4,059 | 18.12.2026 | 0,100 | Morgan Stanley | |
| MM8J8N | | BioNTech SE (ADRs)/OS/Call [104]/MS | - | - | 104,000 | call | BioNTech SE (ADRs) | - | 62,008 % | 0,562 | -0,023 | 2,792 | 17.06.2027 | 0,100 | Morgan Stanley | |
| MM8JV2 | | BioNTech SE (ADRs)/OS/Call [104]/MS | - | - | 104,000 | call | BioNTech SE (ADRs) | - | 64,837 % | 0,375 | -0,051 | 6,417 | 18.09.2026 | 0,100 | Morgan Stanley | |
| MN0F29 | | BioNTech SE (ADRs)/OS/Call [104]/MS | - | - | 104,000 | call | BioNTech SE (ADRs) | - | 73,145 % | 0,639 | -0,020 | 2,040 | 17.12.2027 | 0,100 | Morgan Stanley | |
| MN680Z | | BioNTech SE (ADRs)/OS/Call [104]/MS | - | - | 104,000 | call | BioNTech SE (ADRs) | - | 60,466 % | 0,522 | -0,026 | 3,307 | 19.03.2027 | 0,100 | Morgan Stanley | |
| MR34WK | | BioNTech SE (ADRs)/OS/Call [104]/MS | - | - | 104,000 | call | BioNTech SE (ADRs) | - | 87,790 % | 0,715 | -0,018 | 1,615 | 16.06.2028 | 0,100 | Morgan Stanley | |
| UJ3MH8 | BioNTech SE (ADRs)/OS/Call [104]/UBS | - | - | 104,000 | call | BioNTech SE (ADRs) | - | - | - | - | - | 18.12.2026 | 0,100 | UBS | ||
| UJ6Y00 | BioNTech SE (ADRs)/OS/Call [104]/UBS | - | - | 104,000 | call | BioNTech SE (ADRs) | - | - | - | - | - | 18.09.2026 | 0,100 | UBS | ||
| UJ6KRU | BioNTech SE (ADRs)/OS/Call [104]/UBS | - | - | 104,000 | call | BioNTech SE (ADRs) | - | - | - | - | - | 17.06.2027 | 0,100 | UBS | ||
| PL1NX9 | | BioNTech SE (ADRs)/OS/Call [105]/BNP | - | - | 105,000 | call | BioNTech SE (ADRs) | - | 49,744 % | 0,421 | -0,026 | 5,135 | 18.12.2026 | 0,100 | BNP Paribas | |
| PL1NYE | | BioNTech SE (ADRs)/OS/Call [105]/BNP | - | - | 105,000 | call | BioNTech SE (ADRs) | - | 50,347 % | 0,443 | -0,025 | 4,632 | 15.01.2027 | 0,100 | BNP Paribas | |
| PL84JT | | BioNTech SE (ADRs)/OS/Call [105]/BNP | - | - | 105,000 | call | BioNTech SE (ADRs) | - | 50,803 % | 0,300 | -0,037 | 8,622 | 18.09.2026 | 0,100 | BNP Paribas |